ArticleFrontiers in pharmacology2026

Chronic migraine management with onabotulinumtoxinA and anti-CGRP/R monoclonal antibodies in an Italian real-world setting: update on therapeutic appropriateness and an emerging role of pharmacy.

Damiana Scuteri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.